ZNF217 and acute lymphoblastic leukemia: Our results revealed a significant decrease in the competitive fitness of B-ALL cells carrying sgRNAs targeting ZNF217 compared to their non-targeted counterparts, resembling the trends observed with cells harboring sgRNA targeting common essential genes (MYC and BRD4; Figure 2A-2B and Figure S2A-S2B).